VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2020 | CRISPR and gene editing in clinical practice

Haydar Frangoul, MD, Sarah Cannon Blood Cancer Center, Nashville, TN, discusses the challenges of implementing CRISPR and gene editing in clinical practice. Dr Frangoul emphasizes that patients need to have longer follow-up, and the need for more patients to be enrolled on clinical trials. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020

Disclosures

Haydar Frangoul, MD, is a steering committee member at Vertex Pharmaceutical.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter